News Sequana Medical N.V.

Equities

SEQUA

BE0974340722

Market Closed - Euronext Bruxelles Other stock markets 11:39:15 2024-04-18 am EDT			5-day change	1st Jan Change
1.475 ^EUR	+3.51%		-1.67%	-63.12%

Apr. 03	Sequana Medical Announces Strong Data from DSR Proof-of-Concept Studies in Heart Failure Published in European Journal of Heart Failure	CI
Mar. 28	Sequana Medical NV Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sequana Medical Announces Strong Data from DSR Proof-of-Concept Studies in Heart Failure Published in European Journal of Heart Failure	Apr. 03	CI
Sequana Medical NV Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 27	CI
Sequana Medical NV Announces Three Month Follow-Up Data from MOJAVE Non- Randomized Cohort Confirming Significant Improvement in Diuretic Response and Virtual Elimination of Loop Diuretics Following DSR Therapy	Mar. 25	CI
Sequana Medical Raises EUR11.5 Million via Share Placement	Mar. 21	MT
Sequana Medical's Premarket Application for Alfapump Accepted by US FDA; Shares Rise	Jan. 29	MT
Sequana Medical Receives New US Reimbursement Codes for Alfapump System	Jan. 03	MT
Sequana Medical submits Premarket Approval application to US FDA for alfapump in recurrent or refractory ascites due to liver cirrhosis	Dec. 29	AQ
Belgium's Sequana Medical Seeks US FDA Premarket Approval for Liver Ascites Treatment Device	Dec. 28	MT
Sequana Medical N : announces positive data from non-randomized cohort in US Phase 1/2a MOJAVE study of DSR® 2.0 for treatment of heart failure	Nov. 29	PU
Sequana Medical NV Announces Positive Data from Non- Randomized Cohort in US Phase 1/2a MOJAVE Study of DSR® 2.0 for Treatment of Heart Failure	Nov. 29	CI
Sequana Medical NV Appoints Ids Van Der Weij as Non-Executive Director	Nov. 10	CI
Certain Shares of Sequana Medical NV are subject to a Lock-Up Agreement Ending on 22-OCT-2023.	23-10-21	CI
Transcript : Sequana Medical NV - Special Call	23-10-19
Sequana Medical N : announces additional alfapump data supporting strong and durable clinical profile; PMA on track for year-end submission	23-10-19	PU
Sequana Medical N : announces initial positive data from MOJAVE, a US Phase 1/2a study of DSR® 2.0 for treatment of heart failure through breaking vicious cycle of cardiorenal syndrome	23-10-18	PU
Sequana Medical NV Announces Initial Positive Data from MOJAVE, a US Phase 1/2A Study of DSR 2.0 for Treatment of Heart Failure through Breaking Vicious Cycle of Cardiorenal Syndrome	23-10-18	CI
Sequana Medical N : announces Extraordinary General Meeting of Shareholders on 10 November 2023	23-10-06	PU
Sequana Medical N : Special report of the Board of Directors	23-10-05	PU
Sequana Medical N : ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES	23-10-05	PU
Sequana Medical NV Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-14	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Sequana Medical N.V.

Equities

SEQUA

BE0974340722

Summary

Filters